Cspc Innovation Pharmaceutical Co.,Ltd.’s Net Profit Rose 85.4% in First Half of 2022

Cspc Innovation Pharmaceutical Co.,Ltd. (石药集团新诺威制药股份有限公司) (300765.SZ) reported a net profit of 302.6 million yuan in the first half of 2022, up 85.4% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 46.9% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 290.7 million yuan in total liabilities, with a liability-to-asset ratio of 8.4%.